Form D — Tune Therapeutics, Inc.
0002053139-25-000001 · filed 2025-01-24
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $208,045,929
- Total sold
- $182,414,405
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Tune Therapeutics, Inc.
- CIK
- 2053139
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2020
- Address
- 1930 Boren Avenue, Floor 5
SEATTLE, WA 98101 - Phone
- (855) 755-8863
Related persons
-
Akira Matsuno · Executive OfficerSeattle, WA
-
Ali Behbahani · DirectorSeattle, WA
-
Charles Gersbach · DirectorSeattle, WA
-
Dan McHugh · Executive OfficerSeattle, WA
-
John McHutchison · DirectorSeattle, WA
-
Zachary Hale · Executive OfficerSeattle, WA
-
Derek Jantz · Executive OfficerSeattle, WA
-
Yuan Zhang · Executive OfficerSeattle, WA
-
Blythe Sather · Executive OfficerSeattle, WA
View original on SEC EDGAR.